Research for a Future
without Diabetes

„Research for a future without diabetes – this is the mission of the DZD that inspires and unites us.“

Prof. Martin Hrabě de Angelis, DZD board member

Research for a Future
without Diabetes

"The DZD stands for research to benefit people with diabetes."

Prof. Andreas Birkenfeld, DZD-Sprecher

„The Germany-wide cooperation in the DZD ensures that multicenter studies can be carried out with the required number of participants.“

Prof. Michael Roden, DZD board member


Research for a Future
without Diabetes

„The DZD places particular importance on the fast transfer of lab results to patient care.“

Prof. Michele Solimena, DZD speaker



Research for a Future
without Diabetes

„The special feature of research at the DZD is the close interdisciplinary cooperation between different disciplines.“

Prof. Annette Schuermann, DZD Speaker

DZD - German Center
for Diabetes Research

Neuherberg, 03.03.2021

Matthias Tschöp Receives Berthold Medal for Scientific Excellence

This year’s Berthold Medal, the highest recognition of the German Society of Endocrinology (DGE), goes to Professor Matthias Tschöp, who is CEO of Helmholtz Zentrum München and Alexander-von-Humboldt Professor at Technical University of Munich. Tschöp received the Berthold Medal at the 64th annual meeting of the DGE, the German Congress of Endocrinology, in recognition of his scientific achievements.

Matthias Tschöp has shaped the field of metabolic diseases, diabetes and obesity over the last decades on a global scale. His research has generated several novel preventive and therapeutic approaches for diabetes and obesity.

In 2000, he discovered that the human body relies on a hunger hormone called ghrelin that drives appetite, promotes fat storage and tells the brain when additional calories are needed. Building on this discovery, he collaborated with the chemist Richard DiMarchi to develop a series of novel drug candidates that combine the action profiles of multiple hormones into single molecules. These so-called poly-agonists have proven successful as candidates for the treatment of obesity and type 2 diabetes and are now already progressing through phase 2 and 3 clinical trials.

Today, Matthias Tschöp is serving as the CEO of Helmholtz Zentrum München. His strategic vision is centered on transformative acceleration of the path from basic research breakthroughs to delivering medical solutions for society.

About the award
The Berthold Medal is awarded annually. It is named after the famous German scientist Arnold Adolf Berthold, who is considered the founding father of hormone research, as his experiments were the first to prove the existence of hormones. In his honor, the DGE awards the Berthold Medal internationally to researchers who have made outstanding contributions to the field of hormone research and thus continue Berthold's legacy.

More information (German only)

Press contact

Birgit Niesing

+49 (0)89 3187-3971

Prof. Matthias Tschöp. Source: Helmholtz Zentrum München